Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.

Hormone Molecular Biology and Clinical Investigation, published by WALTER DE GRUYTER GMBH, is a pivotal journal within the realms of Endocrinology, Diabetes and Metabolism, and Molecular Biology, contributing significant insights to the field since its inception in 2010. With an ISSN of 1868-1883 and an E-ISSN of 1868-1891, this esteemed journal operates from its headquarters in Berlin, Germany. As a further testament to its growing influence, the journal has achieved respectable category quartile rankings in 2023, including Q3 in Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous), alongside Q4 in Molecular Biology. While currently not open access, the journal is dedicated to disseminating high-quality research aimed at understanding hormone-related mechanisms, clinical applications, and the biochemical pathways that underpin human health. The rich variety of articles published in Hormone Molecular Biology and Clinical Investigation make it an invaluable resource for researchers, medical professionals, and students seeking to deepen their knowledge in these critical scientific areas.

Frontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

Minerva Endocrinology, published by EDIZIONI MINERVA MEDICA in Italy, serves as a pivotal platform for advancing knowledge in the field of endocrinology, diabetes, and metabolism. With its ISSN 2724-6507 and E-ISSN 2724-6116, the journal has rapidly established a reputable position in academia, achieving impressive rankings such as Q3 in both Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. This enables Minerva Endocrinology to attract a diverse readership, including researchers, healthcare professionals, and students committed to understanding the complexities of endocrine disorders. With annual publications covering breakthroughs and innovative research covering converged years from 2021 to 2024, the journal is devoted to facilitating the dissemination of high-quality studies that advance clinical and laboratory practices. Despite its >Open Access< status, the journal encourages submissions that reflect rigorous scientific inquiry and uphold the highest standards of scholarship, thereby enhancing its role as a significant contributor to the field of internal medicine and endocrinology.

Endocrine Practice is a premier journal dedicated to the dynamic and evolving field of endocrinology, published by Elsevier Inc.. With a significant emphasis on clinical practice, research, and advancements in the multidisciplinary domains of endocrinology, diabetes, and metabolism, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. As a recognized leader in its field, it boasts an impressive impact factor and is ranked in the Q1 quartile for both Endocrinology and Medicine categories, reflecting its high-quality research contributions and relevance to contemporary clinical practice. The journal enjoys a robust reputation, achieving Scopus rankings with a placement of #57 out of 244 in Endocrinology, Diabetes and Metabolism, and #37 out of 128 in Biochemistry, Genetics and Molecular Biology. Although it is not available as open access, Endocrine Practice continues to disseminate critical findings from 2000 through to 2024, ensuring that professionals remain at the forefront of endocrine research and clinical application.